All In Biotech

Drug Trial Radar · NCT00912093

A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

A Phase III Randomized, Double-Blind,Placebo-Controlled, Multicenter Study of Icatibant for Subcutaneous Injection in Patients With Acute Attacks of Hereditary Angioedema (HAE)

Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

98

Actual

Start

Jul 16, 2009

Primary completion

Oct 1, 2010

Study completion Oct 1, 2010

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Jun 3, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being conducted to evaluate the efficacy and safety of icatibant compared to placebo in patients experiencing acute attacks of hereditary angioedema (HAE).

Conditions

  • Hereditary Angioedema

Interventions

  • IcatibantDrug

    Single subcutaneous injection of icatibant, 30 mg

  • PlaceboDrug

    Single subcutaneous injection of matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to Onset of Symptom Relief for an Acute Attack, as Assessed by the PatientTime frame: Up to 120 hours post-dose

Locations

64 sites in 9 countries. Site status is shown where the registry gives one.

  • Primary Care Associates of Alabaster

    Alabaster, Alabama

  • UAB Lung Health Center

    Birmingham, Alabama

  • Medical Research of AZ A Division of Allergy & Immunology Assoc

    Scottsdale, Arizona

  • Little Rock Allergy & Asthma Clinic, PA

    Little Rock, Arkansas

  • Allergy and Asthma Insititute of the Valley

    Granada Hills, California

  • University of California San Diego

    La Jolla, California

  • UCLA - Clinical Immunology & Allergy

    Los Angeles, California

  • Speciality Medical Clinic & Research Center

    Stanford, California

  • Standford University

    Stanford, California

  • Asthma & Allergy Associates, PC

    Colorado Springs, Colorado

  • Medical Associates of Brevard

    Melbourne, Florida

  • University of South Florida Division of Allergy and Immunology

    Tampa, Florida

  • Family Allergy and Asthma Center, PC

    Atlanta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • Research Institute of Deaconess Clinic

    Evansville, Indiana

  • University of Iowa Asthma Center/ Hospitals & Clinics

    Iowa City, Iowa

  • LSUHSC Allergy & Immunology

    Shreveport, Louisiana

  • Institute for Asthman & Allergy, P.C.

    Chevy Chase, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • The Asthma Center

    St Louis, Missouri

  • University of Reno Nevada School of Medicine

    Reno, Nevada

  • STARx Research Center, LLC

    Edison, New Jersey

  • Winthrop University Hospital Clinical Trials Center

    Mineola, New York

  • Mount Sinai School of Medicine

    New York, New York

  • Montefiore Medical Center/Albert Einstein College of Medicine

    The Bronx, New York

  • Allergy Partners of Western North Carolina

    Asheville, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • University of Cincinnati Division of Immunology/Allergy

    Cincinnati, Ohio

  • Optimed Research, LTD

    Columbus, Ohio

  • Tulsa Allergy Clinic

    Tulsa, Oklahoma

  • Baker Allergy, Asthma & Dermatology Research Center LLC

    Lake Oswego, Oregon

  • Valley Clinical Research Center

    Bethlehem, Pennsylvania

  • Penn State Hershey Medical Center

    Hershey, Pennsylvania

  • Children's Hospital of Pittsburgh (of UMPC)

    Pittsburgh, Pennsylvania

  • AARA Research Center

    Dallas, Texas

  • University of Texas Medical Branch (UTMB)

    Galveston, Texas

  • Texas A&M Health Science Center College of Medicine

    Houston, Texas

  • Allergy and Asthma Research Center, P.A.

    San Antonio, Texas

  • University of Utah

    Salt Lake City, Utah

  • Royal Adelaide Hospital

    Adelaide, Australia

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.